The problem of anaphylaxis and mastocytosis

Current Allergy and Asthma Reports

Volumn 9, Issue 1, 2009, Pages 64-70

  Müller, Ulrich R ^a   Haeberli, Gabrielle ^b  

^a Allergy Division   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; ARTHROPOD VENOM; TRYPTASE;

ANAPHYLAXIS; ANIMAL; BLOOD; HUMAN; HYMENOPTERA; IMMUNOLOGY; MAST CELL; MASTOCYTOSIS; REVIEW;

ANAPHYLAXIS; ANIMALS; ANTI-ALLERGIC AGENTS; ARTHROPOD VENOMS; HUMANS; HYMENOPTERA; MAST CELLS; MASTOCYTOSIS; TRYPTASES;

EID: 61549094745     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-009-0010-9     Document Type: Article

References (48)

1. Reimers A, Müller U: Fatal outcome of a Vespula sting in a patient with mastocytosis after Specific immunotherapy with honey bee venom. Swiss Med Wkly 2005, 135(Suppl 144):S14.
2. Müller U, Morris T, Bischof M, et al.: Combined active and passive immunotherapy in honeybee-sting allergy. J Allergy Clin Immunol 1986, 78:115-122. (Pubitemid 16099933)
3. Johansson SGO, Bieber TH, Dahl R, et al.: Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832-836. (Pubitemid 38608590)
4. Sampson HA, Munoz-Furlong A, Campbell RL, et al.: Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphy-laxis Network symposium. J Allergy Clin Immunol 2006, 117: 391-397. (Pubitemid 43190153)
5. Pumphrey RSH: Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000, 30:1144-1150. (Pubitemid 30619768)
6. Yocum MW, Butterfield JH, Klein JS, et al.: Epidemiology of anaphylaxis in Olmstead County: a population based study. J Allergy Clin Immunol 1999, 104:452-456. (Pubitemid 29420446)
7. Helbling A, Thomas H, Müller U, Pichler WJ: Incidence of anaphylaxis with circulatory symptoms. A study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004, 34:285-290. (Pubitemid 38324548)
8. Bohlke K, Davis RL, DeStefano R, et al.: Epidemiology of anaphylaxis among children and adults enrolled in a health maintenance organization. J Allergy Clin Immunol 2004, 113:536-542. (Pubitemid 38338961)
9. Bresser H, Sandner CH, Rakoski J: Emergencies by insect stings in Munich 1992. Allergo J 2005, 7:373-376.
10. Peng MM, Jick H: A population based study of the incidence, cause and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004, 164:317-319. (Pubitemid 38176473)
11. Monneret-Vautrin DA, Morisset M, Flabee J, et al.: Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005, 60:443-451. (Pubitemid 40332968)
12. Valent P, Akin C, Escribano L, et al.: Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007, 37:435-453. (Pubitemid 46817344)
13. Castells MC: Mastocytosis: classification, diagnosis, and clinical presentation. Allergy Asthma Proc 2004, 25:33-36. (Pubitemid 38365566)
14. Brockow K: Markers of severity for systemic mastocytosis in German. Allergo J 2006, 15:273-279.
15. Greenhawt M, Akin C: Mastocytosis and allergy. Curr Opin Allergy Clin Immunol 2007, 74: 387-392. (Pubitemid 47415281)
16. Tefferi A, Pardanani A: Systemic mastocytosis: current concepts and treatment advances. Curr Hematol Rep 2004, 3:197-202.
17. Valent P, Horny HP, Escribano L, et al.: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001, 25:603-625. (Pubitemid 32506768)
18. Wolff K, Komar M, Petzelbauer P: Clinical and histopatho-logical aspects of cutaneous mastocytosis. Leuk Res 2001, 25:519-528. (Pubitemid 32506758)
19. Hartmann K, Metcalfe DD: Pediatric mastocytosis. Hema-tol Oncol Clin North Am 2000, 14: 625-640. (Pubitemid 30436937)
20. Akin C, Metcalfe DD: Systemic mastocytosis. Annu Rev Med 2004, 55: 419-432. (Pubitemid 38316735)
21. Müller U, Helbling A, Hunziker T, et al.: Mastocytosis and atopy: a study in 33 patients with urticaria pigmentosa. Allergy 1990, 45:597-603. (Pubitemid 20376303)
22. González de Olano D, de la Hoz Caballer B, Núñez López R, et al.: Prevalence of allergy and anaphylactic symptoms in 219 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 2007, 37:1547-1555.
23. Jofer C, Behrendt H, Ring J: Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008, 63:226-232.
24. Müller U, Horat W, Wüthrich B, et al.: Anaphylaxis after Hymenoptera stings in 3 patients with urticaria pigmen-tosa. J Allergy Clin Immunol 1983, 72:685-689. (Pubitemid 14210903)
25. Price LA, Satko M: Bee venom allergy in a patient with urticaria pigmentosa. J Allergy Clin Immunol 1987, 79:407-409. (Pubitemid 17023098)
26. Kors JW, van Doormaal JJ, de Monchy JGR: Anaphylac-toid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis. J Intern Med 1993, 233:255-258. (Pubitemid 23100311)
27. Fricker M, Helbling A, Schwartz LB, Müller U: Hymenop-tera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in 10 patients. J Allergy Clin Immunol 1997, 100:11-15. (Pubitemid 27328525)
28. Oude Elberink JNG, de Monchy JGR, Kors JW, et al.: Fatal anaphylaxis after a yellow jacket sting in two patients with mastocytosis. J Allergy Clin Immunol 1997, 99:153-154. (Pubitemid 27074911)
29. Wagner N, Fritze D, Przybilla B, et al.: Fatal anaphylactic sting reaction in a patient with mastocytosis. Int Arch Allergy Immunol 2008, 146:162-163. (Pubitemid 351685480)
30. Pumphrey RSH, Roberts ISD: Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000, 53:273-276. (Pubitemid 30180398)
31. Dodd NJ, Bond MG: Fatal anaphylaxis in systemic masto-cytosis. Clin Pathol 1979, 32:31-34.
32. Vaughan ST, Jones GN: Systemic mastocytosis presenting as profound cardiovascular collapse during anesthesia. Anaesthesia 1998, 53:804-807. (Pubitemid 28391387)
33. Florian S, Kraut MT, Simonitch-Klupp I, et al.: Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 2005, 136:273-280. (Pubitemid 40529199)
34. Ruëff F, Placzek M, Przybilla B: Mastocytosis and Hyme-noptera venom allergy. Curr Opin Allergy Clin Immunol 2006, 6:284-288.
35. Schwartz LB, Yunginger JW, Miller J, et al.: Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989, 83:1551-1555. (Pubitemid 19124110)
36. Schwartz LB, Bradford TR, Rouse C, et al.: Development of a new, more sensitive immunoassay for human trypt-ase: use in systemic anaphylaxis. J Clin Immunol 1994, 14:190-204. (Pubitemid 24182179)
37. Ludolph-Hauser D, Ruëff F, Fries C, et al.: Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001, 357:361-362.
38. Haeberli G, Brönnimann M, Hunziker T, et al.: Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003, 33:1216-1220. (Pubitemid 37108524)
39. Kucharewicz I, Bodzenta-Lukaszyk A, Szymanski W, et al.: Basal serum tryptase level correlates with severity of Hymen optera sting and age. J Investig Allergol Clin Immunol 2007, 17: 65-69. (Pubitemid 46623706)
40. Ruëff F, Bauer M, Placzek M, et al.: Treatment of mastocy-tosis. Allergologie 2006, 29:362-369.
41. Escribano L, Akin C, Castells M, Schwartz LB.: Current options in the treatment of mast cell mediator-related symptoms of mastocytosis. Inflamm Allergy Drug Targets 2006, 5:61-67.
42. Ring J, Brockow K, Duda D, et al.: Emergency treatment of anaphylactic reactions. Allergo J 2007, 16:420-434. (Pubitemid 47606507)
43. Wolff K: Treatment of cutaneous mastocytosis. Int Arch Allergy Immunol 2002, 127:156-159. (Pubitemid 34264207)
44. González de Olano D, Alvarez-Twose I, Esteban-López MI, et al.: Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol 2008, 121:519-526.
45. Bonadonna P, Zanotti R, Caruso B, et al.: Allergen Specific immunotherapy is safe and effective in patients with masto-cytosis and Hymenoptera allergy. J Allergy Clin Immunol 2008, 121:256-257.
46. Kontou-Fili K: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis. Allergy 2008, 63:376-378. (Pubitemid 351224685)
47. Reimers A, Hari Y, Müller U: Reduction of side effects from ultra-rush immunotherapy with honey bee venom by pre-treatment with fexofenadine: a double-blind placebo-controlled trial. Allergy 2000, 55:484-488.
48. Bonifazi F, Jutel M, Bilo BM, et al.: Prevention and treatment of Hymenoptera venom allergy. Allergy 2005, 60:1459-1470.